Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HERKULES-3: ERAS-007 in Advanced Gastrointestinal Malignancies
NCT05039177Phase 2Completed
- Sponsor
- Erasca
- Start
- Sep 2021
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ERAS-007 in colorectal cancer (CRC), pancreatic ductal adenocarcinoma (PDAC), sponsored by Erasca. Started Sep 2021; status: completed.
02
Drugs
ERAS-007
03
Conditions
colorectal cancer (CRC)pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT05039177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05039177.